On 6/10/24, Cryo-Cell International Inc (NYSEAMERICAN: CCEL) stock suffered a major decline of -10.3%, closing at $8.27. However, this decline was accompanied by unusually low trading volume at 54% of normal. The stock has risen 0.6% during the last week and has been exceptionally strong relative to the market over the last nine months.
Current PriceTarget Research Rating
CCEL’s future returns on capital are forecasted to be below the cost of capital. Accordingly, the company is expected to continue to be a major Value Eraser.
Cryo-Cell International is currently unrated.
Rating Review
The stock is currently unrated.
Be the first to comment